Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000434

Chief Executive Officer sold 11,872 shares at an average $222.13 ($2,637,077)

  • Chief Executive Officer acquired 11,772 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kummeth Charles R. · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-27 Exercise or conversion : show line 1 in the form +11,772 $67.46 $794,139 147,628 D
2019-11-27 Sale : show line 2 in the form −11,772 $222.12 $2,614,814 135,856 D
2019-11-29 Sale : show line 3 in the form −100 $222.62 $22,262 135,756 D
Open-market sales · 11,872 sh · avg $222.13 · $2,637,077

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-27 Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) −11,772 45,818 D
Loading xslF345X03/edgar.xml…